Adaptimmune Therapeutics Plc (ADAPY)
0.052
0.00 (0.00%)
USD |
OTCM |
Dec 10, 16:00
Adaptimmune Therapeutics Total Assets (Quarterly): 130.63M for June 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 43.50M |
| Autolus Therapeutics Plc | 661.95M |
| Mereo BioPharma Group Plc | 53.60M |
| Bicycle Therapeutics Plc | 763.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 201.59M |
| Shareholders Equity (Quarterly) | -70.96M |
| Debt to Equity Ratio | -0.686 |
| Current Ratio | 1.516 |
| Net Debt Paydown Yield | -7.87% |